Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Clearside Biomedical, Inc. | clsd-ex321_7.htm |
| EX-31.2 - EX-31.2 - Clearside Biomedical, Inc. | clsd-ex312_8.htm |
| EX-31.1 - EX-31.1 - Clearside Biomedical, Inc. | clsd-ex311_6.htm |
| EX-10.21 - EX-10.21 - Clearside Biomedical, Inc. | clsd-ex1021_665.htm |
| 10-K - CLSD-10K-20161231 - Clearside Biomedical, Inc. | clsd-10k_20161231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-212014) pertaining to the 2011 Stock Incentive Plan, as amended, Stock Option Awards, 2016 Equity Incentive Plan, and 2016 Employee Stock Purchase Plan of Clearside Biomedical, Inc. of our report dated March 16, 2017, with respect to the financial statements of Clearside Biomedical, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2016.
/s/Ernst & Young LLP
Atlanta, Georgia
March 16, 2017